Google DeepMind CEO Demis Hassabis heads Gemini and the company's AI push while gaining more power. Here's how he became ...

Searches on Apple devices are falling for the first time ever as more and more young people are turning to smart chatbots ...

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

The latest example of trouble resulting from this definitional confusion comes from the deteriorating relationship between ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology ...

Google DeepMind’s Demis Hassabis on his Nobel Prize: ‘It feels like a watershed moment for AI’ The founder of the artificial intelligence R&D lab says scientific understanding can prevent ...

Point one: AI climate tech that looks great in the lab can struggle in real life. Scientists this week claimed a Meta ...

The EU AI Champions Initiative is a group of about 70 financial, technology, and industrial companies that is not an ...

Google DeepMind won bragging rights that its competitors in the field of AI could only dream of. A share of the 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis, its CEO, and John Jumper, ...

The number of scientific papers that rely on AI has quadrupled, and the scope of problems AI can tackle is expanding by the day.